These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11514172)

  • 21. Studies on cyclin-dependent kinase inhibitors: indolo-[2,3-a]pyrrolo[3,4-c]carbazoles versus bis-indolylmaleimides.
    Sanchez-Martinez C; Shih C; Zhu G; Li T; Brooks HB; Patel BK; Schultz RM; DeHahn TB; Spencer CD; Watkins SA; Ogg CA; Considine E; Dempsey JA; Zhang F
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3841-6. PubMed ID: 14552792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library design.
    Honma T; Hayashi K; Aoyama T; Hashimoto N; Machida T; Fukasawa K; Iwama T; Ikeura C; Ikuta M; Suzuki-Takahashi I; Iwasawa Y; Hayama T; Nishimura S; Morishima H
    J Med Chem; 2001 Dec; 44(26):4615-27. PubMed ID: 11741479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dimerization of the amino terminal domain of p57Kip2 inhibits cyclin D1-cdk4 kinase activity.
    Reynaud EG; Guillier M; Leibovitch MP; Leibovitch SA
    Oncogene; 2000 Feb; 19(9):1147-52. PubMed ID: 10713702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin-dependent kinase inhibitors for treating cancer.
    Toogood PL
    Med Res Rev; 2001 Nov; 21(6):487-98. PubMed ID: 11607930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aloisines, a new family of CDK/GSK-3 inhibitors. SAR study, crystal structure in complex with CDK2, enzyme selectivity, and cellular effects.
    Mettey Y; Gompel M; Thomas V; Garnier M; Leost M; Ceballos-Picot I; Noble M; Endicott J; Vierfond JM; Meijer L
    J Med Chem; 2003 Jan; 46(2):222-36. PubMed ID: 12519061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity.
    Alessi F; Quarta S; Savio M; Riva F; Rossi L; Stivala LA; Scovassi AI; Meijer L; Prosperi E
    Exp Cell Res; 1998 Nov; 245(1):8-18. PubMed ID: 9828096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-Aminoquinazoline inhibitors of cyclin-dependent kinases.
    Bathini Y; Singh I; Harvey PJ; Keller PR; Singh R; Micetich RG; Fry DW; Dobrusin EM; Toogood PL
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3881-5. PubMed ID: 15993068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6.
    Noh SJ; Li Y; Xiong Y; Guan KL
    Cancer Res; 1999 Feb; 59(3):558-64. PubMed ID: 9973200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.
    Fåhraeus R; Laín S; Ball KL; Lane DP
    Oncogene; 1998 Feb; 16(5):587-96. PubMed ID: 9482104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
    Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. G1 phase arrest by the phosphatidylinositol 3-kinase inhibitor LY 294002 is correlated to up-regulation of p27Kip1 and inhibition of G1 CDKs in choroidal melanoma cells.
    Casagrande F; Bacqueville D; Pillaire MJ; Malecaze F; Manenti S; Breton-Douillon M; Darbon JM
    FEBS Lett; 1998 Feb; 422(3):385-90. PubMed ID: 9498822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin-dependent kinase 4.
    Kubo A; Nakagawa K; Varma RK; Conrad NK; Cheng JQ; Lee WC; Testa JR; Johnson BE; Kaye FJ; Kelley MJ
    Clin Cancer Res; 1999 Dec; 5(12):4279-86. PubMed ID: 10632371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploiting structural principles to design cyclin-dependent kinase inhibitors.
    Noble M; Barrett P; Endicott J; Johnson L; McDonnell J; Robertson G; Zawaira A
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):58-64. PubMed ID: 16361058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural analysis of the inhibition of Cdk4 and Cdk6 by p16(INK4a) through molecular dynamics simulations.
    Villacañas O; Pérez JJ; Rubio-Martínez J
    J Biomol Struct Dyn; 2002 Dec; 20(3):347-58. PubMed ID: 12437373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small molecule cyclin-dependent kinase inhibitors protect against neuronal cell death in the ischemic-reperfused rat retina.
    Sakamoto K; Ohki K; Saito M; Nakahara T; Ishii K
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):419-25. PubMed ID: 21714634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imidazo[1,2-a]pyridines. Part 2: SAR and optimisation of a potent and selective class of cyclin-dependent kinase inhibitors.
    Byth KF; Culshaw JD; Green S; Oakes SE; Thomas AP
    Bioorg Med Chem Lett; 2004 May; 14(9):2245-8. PubMed ID: 15081017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-alpha-induced G1 phase arrest through up-regulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages.
    Matsuoka M; Tani K; Asano S
    Oncogene; 1998 Apr; 16(16):2075-86. PubMed ID: 9572488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-based design and synthesis of 2-benzylidene-benzofuran-3-ones as flavopiridol mimics.
    Schoepfer J; Fretz H; Chaudhuri B; Muller L; Seeber E; Meijer L; Lozach O; Vangrevelinghe E; Furet P
    J Med Chem; 2002 Apr; 45(9):1741-7. PubMed ID: 11960485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1).
    Cheng M; Sexl V; Sherr CJ; Roussel MF
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1091-6. PubMed ID: 9448290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.